Analiza ekspresije gena u koštanom tkivu osteoporotičnih miševa by Iva Orlić et al.
3
DOI: 10.2478/v10004-007-0001-y
Conference Paper / Original Scientific Paper
GENE EXPRESSION PROFILING IN BONE TISSUE 
OF OSTEOPOROTIC MICE
Iva ORLI]1, Fran BOROVE^KI2, Petra [IMI]1, and Slobodan VUKI^EVI]1
Department of Anatomy, Medical School University of Zagreb1, Center for Functional Genomics, University 
Hospital, Medical School University of Zagreb2, Zagreb, Croatia
Received in December 2006
Accepted in January 2007
Ovaricetomized (OVX) animals represent an optimal model to investigate bone loss in osteoporosis. To 
further elucidate the underlying mechanisms of decreased bone formation and increased bone resorption 
following OVX, we conducted gene expression profiling experiments using bone samples of ovariectomized 
C57BL/6J mice. Following OVX, genes involved in immune response, cell cycle regulation, growth, 
apoptosis and bone resorption were upregulated, while genes that are important for regular cell processes, 
mitosis, metabolism of carbohydrates, extracellular matrix structure, angiogenesis, skeletal development 
and morphogenesis were downregulated. Among bone specific genes we observed upregulation of 
interleukin 7 (IL-7), IL-7 receptor and matrix metallopeptidase 8, while genes such as transforming growth 
factor-beta 3, procollagen type I and procollagen type VI exhibited marked decrease in expression. We 
also observed downregulation of two genes, parathyroid hormone receptor 1 and WD repeat domain 5, 
that are involved in skeletal development but were not previously reported to be altered in osteoporosis. 
We further performed gene set enrichment analysis (GSEA) in order to calculate enrichment of pathways 
specifically altered in murine bones following ovariectomy.
In conclusion, OVX greatly influences expression of various genes involved in diverse biological 
processes confirming the notion that numerous pathways play an important role in pathophysiology of 
osteoporosis.
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Osteoporosis is a skeletal disease characterized by 
low bone mass and microarchitectural deterioration 
with a resulting increase in bone fragility and subsequent
susceptibility to fracture (1). One of the most important 
traits of osteoporosis is low bone mineral density 
(BMD) (2). The decrease in bone mass observed 
in osteoporosis stems from the imbalance in bone 
remodeling where bone resorption by osteoclasts 
exceeds osteoblastic bone formation. In healthy 
adults, skeleton bone remodeling is responsible 
for the maintenance of the bone volume and 
architecture. Cellular interactions occurring within a 
remodeling cycle are divided into four main events: 
activation, resorption, reversal, and formation (3). In 
the state of estrogen deficiency there is a remodeling 
imbalance with a substantial increase in bone turnover. 
This imbalance leads to the progressive loss of 
trabecular and cortical bone, partly due to increased 
osteoclastogenesis.
In the last 20 years the expression of genes involved 
in bone metabolism and particularly in the onset and 
development of osteoporosis has been extensively 
studied (4). Previous studies have shown that 
osteoporosis involves complex control mechanisms 
which involve multiple factors, such as hormones, 
cytokines, various receptors, etc. Numerous genes are 
known to be differentially expressed in postmenopausal 
women with lower BMD and osteoporotic fractures as 
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compared to postmenopausal women with normal 
bone density. These include interleukin 1 α (IL-1 α),
IL-1 ß and IL-6 which were shown to be significantly 
expressed in bone samples of osteoporotic individuals 
(5). Furthermore, three genes with putative role in 
bone metabolism, namely CCR3 (chemokine receptor 
3), HDC (histidine decarboxylase, i.e. the histamine 
synthesis enzyme), and GCR (glucocorticoid receptor) 
were upregulated in circulating monocytes of subjects 
with low BMD (6). In addition, increased production of 
IL-1 and tumour necrosis factor α (TNF-α) has been 
observed in circulating mononuclear cells in women 
with postmenopausal osteoporosis (7, 8).
Because of the complex etiology of osteoporosis, 
which entails a large number of genes both in its onset 
and progression, microarray technique represents 
a powerful tool for unraveling of the intricate 
mechanisms involved. Ovariectomized (OVX) animals 
represent an optimal animal model to investigate bone 
loss in osteoporosis (9). Previous gene expression 
profiling experiments performed on femurs of OVX 
and vehicle-treated rats, revealed a specific profile of 
644 differentially expressed genes when compared to 
sham control rats (10). At 40 days following OVX there 
was an increase in expression of genes associated 
with bone formation (Col1a2, Col5a1, osteocalcin, 
osteonectin and decorin), while osteoclastic genes 
(i.e., cathepsin K, tartrate resistant acid phosphatase 
and calcitonin receptor) were either not expressed 
above the background level or were not significantly 
changed by OVX (10).
We have previously shown that OVX in mice of the 
C57BL/6J strain leads to trabecular and cortical bone 
loss at both axial and appendicular sites, as indicated 
by lower BMD values of the femur, tibia and lumbar 
spine (11, 12). In order to further elucidate changes 
in transcription caused by OVX, we have performed 
microarray gene expression profiling experiments 
using bone samples of sham and OVX mice.
MATERIALS AND METHODS
Animals
Wild type C57BL/6J mice were purchased from 
Charles River, Budapest, Hungary. Animals were 
housed in groups of five in stainless-steel wire 
mesh-bottomed cages. Food (2014S rat/mice diet, 
Harlan Teklad, Winhelmann GmbH) and water were 
available ad libitum. Animals were maintained in 
accordance with the NIH Guide for the Care and Use of 
Laboratory Animals (13), and protocols were approved 
by Institutional Ethics Committee and Ministry of 
Science Grant Review Committee. At three months 
of age in sham mice (n=5) ovaries were exteriorized 
but replaced intact, while bilateral OVX with dorsal 
approach was performed in the remaining mice (n=5). 
OVX animals were left untreated for 3 weeks following 
surgery to await the development of osteoporosis 
when they were sacrificed. 
RNA isolation and gene expression profiling
Total RNA was extracted from whole murine femur 
samples using TRIzol reagent (Invitrogen, Carlsbad, 
CA, USA) and RNeasy® Mini Kit (Qiagen, Hilden, 
Germany) according to manufacturer’s protocol. 
The quality of total RNA was analyzed using the 
RNA 6000 Nano LabChip kit on a 2100 Bioanalyzer 
(Agilent Technologies, Palo Alto, CA, USA). Microarray 
analysis was performed using Mouse Genome 430 
2.0 GeneChips (Affymetrix, Santa Clara, CA, USA), 
which contains 45 000 25-mer probe sets. The RNA 
was processed using the standard Affymetrix protocol. 
Briefly, using One-Cycle cDNA Synthesis kit and 
IVT Labeling kit (Affymetrix), 5 µg of total RNA were 
transcribed into biotin-labeled cRNA. Labeled cRNA 
probe was hybridized overnight to Mouse Genome 430 
2.0 GeneChips (Affymetrix). Following hybridization, 
arrays were washed, fluorescently tagged and 
scanned, using the Affymetrix GeneChip Scanner 
3000. Usual quality measures and normalization for 
the Affymetrix GeneChip (3’/5’ ratios and trimmed 
mean normalization) were used in the experiments. All 
arrays were run in the same core facility at Center for 
Functional Genomics, School of Medicine, University 
of Zagreb.
Statistical analysis
Gene Chip data was analyzed using the Affymetrix 
GCOS 1.2 software, Excel, Access, DChip and 
GeneSpring 7.2 software. The data was normalized 
and filtered according to expression level. The Student 
T-test was used to determine significant changes in 
gene expression between sham and OVX groups of 
animals. Significant genes were selected according 
to cut-off values of P < 0.05 and fold change < 0.6 
and > 1.8.
Gene Set Enrichment Analysis
In an effort to test the functional correlation of 
gene sets that might be systemically altered in OVX 
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mice, we applied a statistical method called Gene 
Set Enrichment Analysis (14). GSEA was developed 
for analysis of genome-wide expression experiments, 
using the principle of gene-ranking based on the 
correlation between their expression and the class 
distinction by applying the signal-to-noise ratio metric. 
Using the freely available GSEA-P software and a set 
of 522 predefined functional groups, we performed 
GSEA on a database of 10 gene expression profiles 
of sham and OVX mice.
RESULTS
Differential expression of genes following OVX
After filtering probe sets with signal below the target 
intensity of 100, 9423 probe sets were further analyzed. 
The transcripts were further divided into upregulated 
(fold change higher than 1.8) and downregulated 
(fold change lower than 0.6), while transcripts with 
fold change between 0.6 and 1.8 were left out of the 
subsequent analysis. OVX mice exhibited considerably 
higher number of downregulated transcripts, with 137 
upregulated and 348 downregulated genes. 
Among the transcripts significantly over-expressed 
following OVX, several functional groups and 
pathways were significantly represented. Most 
notably, the upregulated transcripts included genes 
involved in bone resorption, such as interleukin 7, 
intreleukin 7 receptor and matrix metallopeptidase 
8 (Table 1). Genes involved in immune response, 
for example eosinophil peroxidase, proteoglycan 3, 
major histocompatibility complex (MHC) class I H2-
L-d, chemokine (C-C motif) receptor 2, MHC class 
I H-2Ds and histocompatibility 2 M region locus 3 
were significantly upregulated as well. It is important 
to stress that Smad 4, a well-described downstream 
molecule in the BMP and TGF-beta signaling 
also exhibited significantly increased expression, 
implicating activation of mechanisms involved in bone 
formation. Other upregulated transcripts included 
genes involved in growth and apoptosis, such as 
growth arrest specific 5, S-phase kinase-associated 
protein 2 (p45), and apoptosis inhibitor 5. Processes 
like nucleic acid binding (eosinophil-associated 
ribonuclease 1), regulation of transcription (signal 
transducer and activator of transcription 1) and 
protein transport (sorting nexin 5) were also affected 
by OVX. 
Genes involved in skeletal development and 
morphogenesis, such as receptor-like tyrosine kinase, 
parathyroid hormone receptor 1 and WD repeat 
domain 5 were among the significantly decreased 
transcripts. It is also important to stress that the 
latter two genes have not been shown previously 
to be significantly decreased following OVX. Genes 
that code for proteins important in extracellular 
matrix, namely procollagen type I α 1, peptidoglycan 
recognition protein 1 and procollagen type VI α 2, were 
also decreased in expression. Vascular endothelial 
growth factor B was downregulated by 1,7 fold in bone 
tissue of OVX mice indicating impaired vascularization 
following ovariectomy.
Overall, regular cellular processes, such as 
rRNA processing, transcription, protein production, 
binding and modification, represented by decreased 
expression of nucleoplasmin 3, RNA polymerase II, 
TSC22 domain family member 1, triadin and thyroid 
hormone receptor interactor 12, were adversely 
affected by OVX. Cell cycle was also deregulated as 
indicated by decreased expression of genes involved 
in mitosis and cell cycle regulation, namely tubulin 
ß 5, cyclin A2, interferon-related developmental 
regulator 2, cyclin E1, transforming growth factor 
-beta 3, cyclin A2 and cyclin D3. The metabolism 
of carbohydrates was impaired as well, mainly 
through inhibition of glycolysis and fructosamine 
metabolism (fructosamine 3 kinase, enolase 3 ß and 
phosphofructokinase) (Table 2).
Gene Set Enrichment Analysis reveals activation 
of bone resorption in OVX mice
To further elucidate the underlying mechanisms 
of bone metabolism following OVX we calculated the 
enrichment scores (ES) of 522 predefined gene sets 
(MSigDB1, Broad Institute, Boston, USA) containing 
genes involved in specific metabolic and signaling 
pathways (14). Estimated statistical significance 
(nominal P value) of the ES was also calculated by
using an empirical phenotype-based permutation 
test procedure that preserves the complex correlation 
structure of the gene expression data. Nominal P 
value of P<0.05 was taken as a cut-off value in the 
analysis.
Using GSEA we tried to identify functional sets 
specifically enriched in ovariectomized animals (Figure 
1). The SHAM>OVX analysis revealed significant 
enrichment of insulin-like growth factor-1 (IGF-1) 
related pathways, including IGF-1 receptor pathway, 
insulin signaling pathway, glycogen metabolism, as 
well as glycolysis and gluconeogenesis. Cell cycle 
and vascular endothelial growth factor gene sets were 
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Response to oxidative 
stress
NM_007946.1 1449136_at eosinophil peroxidase Epx 5.82 0.0130
Immune response NM_016914.1 1449924_at proteoglycan 3 Prg3 4.61 0.0026
Immune response M33151.1 1426324_at
histocompatibility
2D region locus 1
MHC H2Ld 3.83 0.0387






















Antigen presentation M34962.1 1451683_x_at
histocompatibility
2. L region
MHC H2Dr 2.34 0.0489
Growth factor activity NM_022024.2 1419193_a_at










IL receptor activity NM_008372.2 1448575_at interleukin 7 receptor Il7r 2.12 0.0499
Bone resorption BG069762 1436861_at interleukin 7 Il7 1.99 0.0244
Filament-based
process
AV147875 1438118_x_at vimentin Vim 1.99 0.0359




Protein transport NM_024225.1 1417646_a_at sorting nexin 5 Snx5 1.85 0.0096
Morphogenesis NM_008540.2 1422485_at MAD homolog 4 Smad4 1.82 0.0440
Collagen catabolism NM_008611.1 1449366_at matrix metallopeptidase 8 Mmp8 1.80 0.0086
Apoptosis AV118744 1439214_a_at apoptosis inhibitor 5 Api5 1.80 0.0039
Differential expression of genes in femurs of WT sham vs. OVX animals. Genes were ranked according to 
the fold change. The fold changes were calculated based on expression values of 5 independent biological 
replicates per group. 
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rRNA processing, protein 
folding
BB811478 1423522_at Nucleoplasmin 3 Npm3 0.21 (-4.76) 0.0032
Transcription U37500.1 1426242_at RNA polymerase II Polr2a 0.29 (-3.51) 0.0037
Mitotic spindle assembly BG064086 1455719_at tubulin, ß 5 Tubb5 0.31 (-3.46) 0.0177
Mitosis NM_009828.1 1417910_at cyclin A2 Ccna2 0.39 (-2.54) 0.0022
Fructosamine metabolism NM_022014.2 1418311_at fructosamine 3 kinase Fn3k 0.42 (-2.41) 0.0317













Ryk 0.48 (-2.06) 0.0023
Regulation of cell cycle NM_007633.2 1416492_at cyclin E1 Ccne1 0.52 (-1.93) 0.0078
Glycolysis NM_007933.1 1417951_at enolase 3, ß muscle Eno3 0.53 (-1.90) 0.0083
Regulation of transcription AU016382
1433899_
x_at
TSC22 domain family, 
member 1
Tsc22d1 0.53 (-1.89) 0.0097
ECM structural molecule BI794771 1455494_at
procollagen,
type I, α 1
Col1a1 0.53 (-1.88) 0.0080









triadin Trdn 0.54 (-1.84) 0.0251
Calcium ion binding NM_013469.1 1418468_at annexin A11 Anxa11 0.55 (-1.80) 0.0105
Skeletal development BC013446.1 1417092_at
parathyroid hormone 
receptor 1






Trip12 0.58 (-1.75) 0.0148
Regulation of cell cycle X75483.1 1417911_at cyclin A2 Ccna2 0.58 (-1.72) 0.0236






Vegfb 0.59 ( -1.70) 0.0003
Regulation of glycolysis NM_021514.2 1416780_at
phosphofructokinase,
muscle
Pfkm 0.60 (-1.68) 0.0140
Regulation of cell cycle NM_007632.1 1415907_at cyclin D3 Ccnd3 0.60 (-1.66) 0.0025
ECM structural molecule BI455189 1426947_x_at
procollagen,
type VI, α 2
Col6a2 0.60 (-1.66) 0.0101
Peptidoglycan catabolism NM_009402.2 1449184_at
peptidoglycan
recognition protein 1
Pglyrp1 0.60 (-1.66) 0.0353
Differential expression of genes in femurs of WT sham vs. OVX animals. Genes were ranked according to 
the fold change. The fold changes were calculated based on expression values of 5 independent biological 
replicates per group. 
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also highly enriched in SHAM animals, indicating 
increased cell proliferation and vascularization prior to 
ovariectomy. The reciprocal OVX>SHAM comparison 
revealed increased enrichment of fatty acid metabolism, 
IL-12 and tumor necrosis factor receptor 2 (TNFR2) 
pathways, indicating increased cytokine production 
in ovariectomized animals. Enrichment of caspase 
pathway might indicate increased rate of apoptosis 
in these animals. Furthermore, proteasome pathway 
was also significantly enriched following OVX, pointing 
to increased protein degradation.
DISCUSSION
Although widely studied, complex etiology of 
osteoporosis has still not been fully elucidated. 
Ovariectomy of mature mice induces cancellous and 
cortical bone loss in axial and appendicular sites. 
Since these changes mimic processes observed in 
postmenopausal women (15), this model has been 
widely used to study etiology of osteoporosis (9). In 
this study, we identified genes that are altered following 
OVX and could account for observed bone loss. 
Most notably, at 21 days following OVX we 
observed upregulation of genes involved in bone 
resorption, suggesting that this time point is very 
close to the initial peak of osteoclastic activity. Among 
the genes with increased gene expression, we have 
observed upregulation of interleukin 7 (IL-7) and 
IL-7 receptor. IL-7 is a lymphopoietic cytokine that 
promotes osteoclastogenesis by upregulating key T 
cell–derived osteoclastogenic cytokines, including 
receptor activator of NF-KB ligand (RANKL), and by 
increasing the number of early precursors of the B 
cell lineage in the bone marrow, a population that has 
been suggested to have the capacity to differentiate 
into osteoclasts (16, 17). IL-7 receptor knockout mice 
display increased bone volume and bone mineral 
density (16). 
Another evidence confirming increased bone 
resorption in bone samples of OVX mice is elevated 
expression of Mmp-8, which has been previously 
reported as increased in bone marrow stromal cells 
from osteoporotic rats (18). Mmp-8 is expressed in a 
wide range of cells mainly in the course of different 
inflammatory conditions. Besides being an efficient 
collagen degrading protease (collagen type I > type 
III > type II), Mmp-8 also cleaves a wide range of 
non-collagenous substrates, such as serine protease 
inhibitors and several chemokines (19). 
Following OVX we observed a significant 
upregulation of various genes that are involved in 
immune response (eosinophil peroxidase, proteoglycan 
3, MHC class I H2-L-d, proteoglycan 2, chemokine 
(C-C motif) receptor 2, MHC class I H-2Ds and 
histocompatibility 2 M region locus 3), which supports 
the notion that in estrogen deficient state upregulation 
of molecules involved in immune response induces 
bone loss (20). It has been previously shown that 
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Figure 1 Gene set enrichment analysis (GSEA) reveals pathways significantly altered in ovariectomized animals. A) The “butterfly plot” showing the 
observed correlation, as well as negative and positive permuted correlation, for the top 100 genes. B) Plot of p values versus normalized
enrichment scores, showing a higher proportion of significantly enriched gene sets in the sham group of animals.
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OVX upregulates T cell TNF production primarily by 
increasing the number of TNF-producing T cells (21) 
and that due to the elevated TNF production, bone 
resorption is increased. 
Among genes involved in immune response we 
observed upregulation of chemokine receptor 2 (Ccr2). 
It has been suggested that upregulation of another 
chemokine receptor, CCR3 in circulating monocytes 
of individuals with low BMD may facilitate both the 
access of monocytes to the bone microenvironment
and their subsequent differentiation into osteoclasts 
(6). Since it was shown that chemokine receptors 
CCR2b and CCR4 were potently induced by RANKL 
(22), we suggest that increased expression of Ccr2 was 
rather a consequence of elevated RANKL production 
due to increased bone remodeling, than a direct cause 
of increased bone resorption. 
Gene set enrichment analysis was highly concordant
with observed differentially expressed genes. Among 
the pathways enriched in the ovariectomized animals, 
gene sets involved in bone resorption, such as fatty acid 
metabolism, IL-12 and tumor necrosis factor receptor
2 (TNFR2) pathways, were significantly enriched. Other 
pathways, such as caspase and proteasome pathways, 
were also indicative of increased catabolism, and in 
accordance with individual gene changes observed. 
In our study we have also observed downregulation 
of transforming growth factor-beta 3 (TGF-beta 3). 
TGF-beta and IL-7 inversely regulate each other’s 
production. The reduction in TGF-beta signaling, 
characteristic of estrogen deficiency, may serve to 
further stimulate IL-7 production, thus driving the 
cycle of osteoclastogenic cytokine production and 
bone wasting (20). It was shown that ovariectomy 
enhances the production of the osteoclastogenic 
cytokine IL-7, and that its neutralization in vivo 
prevents OVX-induced bone loss (23). It has also 
been reported that OVX significantly reduces mRNA 
expression level of TGF-beta in bone (24) and that
TGF-beta 3 inhibits osteoclast differentiation, 
suggesting its role in estrogen-mediated bone 
maintenance (25). We have observed an upregulation 
of both IL-7 and IL-7 receptor, and downregulation 
of TGF-beta 3 confirming strong influence of IL-7 on 
bone resorption (16,17), effect of TGF-beta 3 decrease 
on pronounced osteoclast differentiation (25) and IL-7 
– TGF-beta dependent cycle (20).
Although it was reported that OVX induces an 
increase in expression of bone formation associated 
genes (Col1a2, Col5a1, osteocalcin, osteonectin 
and decorin) (10), we observed a downregulation of 
Col1a1 and Col6a2. These data are inconsistent most 
likely because of different time points of RNA isolation 
(40 days compared to 21 days) resulting in different 
phases of bone remodeling. 
In this study we have observed downregulation 
of two genes (Pthr1 and Wdr5) that are known to be 
important for skeletal development, but alternation 
of their expression in osteoporosis was not previously 
reported. Pthr1 mediates most of the traditional 
actions of PTH in mineral ion homeostasis and 
is critical to its actions on bone and kidney (26), 
while Wdr5 accelerates osteoblast and chondrocyte 
differentiation in vitro, and is developmentally 
expressed in osteoblasts, as well as in proliferating and 
hypertrophic chondrocytes (27). Observed reduction 
in expression of Pthr1 and Wdr5 in OVX mice suggests 
impaired activity of endogenous PTH on bone tissue 
and decreased osteoblast differentiation resulting in 
imbalanced bone remodeling. 
CONCLUSION
We have shown that OVX greatly influences 
various genes involved in diverse biological processes, 
confirming the notion that numerous pathways play an 
important role in the pathophysiology of osteoporosis 
(23). Specifically, we discovered novel downregulation 
of two genes, Pthr1 and Wdr5, which are involved 
in the skeletal development but were not previously 
reported to be altered in osteoporosis. 
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Sa`etak
ANALIZA EKSPRESIJE GENA U KO[TANOM TKIVU OSTEOPOROTI^NIH MI[EVA
Osteoporoza je naj~e{}a metaboli~ka bolest kostiju, obilje`ena smanjenom ko{tanom masom i 
poreme}enom ko{tanom mikroarhitekturom. Prikladan `ivotinjski model za istra`ivanje osteoporoze su 
ovarijektomirani mi{evi. Kako bismo pobli`e istra`ili mehanizme smanjene ko{tane formacije i poja~ane 
ko{tane razgradnje nakon ovarijektomije, proveli smo pokuse ekspresijskog profiliranja koriste}i se uzorcima 
kostiju ovarijektomiranih mi{eva soja C57BL/6J. Nakon ovarijektomije poja~ava se izra`aj gena uklju~enih 
u imunolo{ki odgovor, regulaciju stani~nog ciklusa, apoptozu i ko{tanu razgradnju, dok se ekspresija gena 
bitnih za mitozu, metabolizam ugljikohidrata, razvoj kosti, strukturu izvanstani~nog matriksa i angiogenezu 
smanjuje. Od ko{tano specifi~nih gena, interleukin 7 (IL-7), receptor za IL-7 i matriks metalopeptidazu 8 
imali su poja~an izra`aj, dok je za transformiraju}i ~imbenik rasta -beta 3, prokolagen tipa I i tipa VI uo~en 
smanjen genski izra`aj. Tako|er smo otkrili smanjen izra`aj dvaju gena, i to receptora 1 za paratireoidni 
hormon i WD ponavljaju}u domenu 5, koji su bitni za ko{tani razvoj, a promjena njihove regulacije nije 
do sada primije}ena u osteoporozi. Kako bismo dodatno istra`ili oboga}enost pojedinih funkcionalnih 
skupina gena u kostima ovarijetkomiranih `ivotinja, podatke smo analizirali s pomo}u algoritma gene set 
enrichment analysis (GSEA).
Zaklju~no, ovarijektomija zna~ajno utje~e na izra`aj brojnih gena uklju~enih u razli~ite biolo{ke procese, {to 
potvr|uje pretpostavku da mnogi molekularni putovi imaju va`nu ulogu u patofiziologiji osteoporoze. 
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